$TKMR Headlines Ebola play Tekmira Pharmaceuti
Post# of 145207
Posted On: 10/02/2014 1:58:00 PM
$TKMR Headlines
Ebola play Tekmira Pharmaceuticals shares drop 2.4% 9:35 a.m. Today - Sue Chang
Newscast: Stocks swoon to start October 6:27 p.m. Oct. 1, 2014 - MarketWatch
U.S. stocks skid; Russell 2000 in correction territory 4:34 p.m. Oct. 1, 2014 - Barbara Kollmeyer
Getting Ebola treatments to market may take time 3:04 p.m. Oct. 1, 2014 - Russ Britt
6 stocks to watch 2:08 p.m. Oct. 1, 2014 - The Trading Deck
Tekmira Pharmaceuticals shares jump 20% 9:33 a.m. Oct. 1, 2014 - Sue Chang
Profiting from the fear as the market’s best quarter of the year begins 8:58 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira may launch clinical trial of Ebola drug later this year: RBC 8:19 a.m. Oct. 1, 2014 - Ciara Linnane
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Sue Chang
Tekmira Pharmaceuticals shares up 27% in premarket trade 8:03 a.m. Oct. 1, 2014 - Ciara Linnane
FAA orders screen switch 2:33 a.m. Oct. 1, 2014 - MarketWatch
Tekmira Pharma shares pop on first U.S. Ebola case 7:43 p.m. Sept. 30, 2014 - Wallace Witkowski
Newscast: Wall Street notches winning quarter 6:31 p.m. Sept. 30, 2014 - MarketWatch
Tekmira shares jump 14% on report of U.S. Ebola case 4:48 p.m. Sept. 30, 2014 - Wallace Witkowski
End of QE turns institutions into sellers 3:19 p.m. Sept. 23, 2014 - The Trading Deck
Charting the bull-bear debate 11:50 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the bull-bear debate 11:32 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the next technical target: Dow 17,750 11:20 a.m. Sept. 18, 2014 - Michael Ashbaugh
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Today - Seeking Alpha
Tekmira Pharmaceuticals (TKMR) Is Today's Perilous Reversal Stock 9:48 a.m. Today - TheStreet.com
Thumbs Up for REITs, Down for Ebola Stocks? 7:42 a.m. Today - Barrons.com
Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% 4:39 p.m. Oct. 1, 2014 - GuruFocus.com
Stock Market Today: Stocks Dive With Utilities the Only Winning Sector 4:36 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Dow Drops 250 Points as Trouble Brews 3:29 p.m. Oct. 1, 2014 - TheStreet.com
3 Stocks Soaring on Spread of Ebola Virus Epidemic - Stocks in the News 1:48 p.m. Oct. 1, 2014 - Zacks.com
Ebola-Related Pharma Stocks Soar On First U.S. Case 1:20 p.m. Oct. 1, 2014 - Investors Business Daily
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today 12:22 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Stocks Decline as Investors Remain Uneasy 11:41 a.m. Oct. 1, 2014 - TheStreet.com
Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks 10:08 a.m. Oct. 1, 2014 - TheStreet.com
Today's Market: Biotech Stocks To Buy For Their Ebola Vaccines 9:35 a.m. Oct. 1, 2014 - Seeking Alpha
Stock Market Today: Futures Slip as U.S. Private Sector Adds Jobs 8:28 a.m. Oct. 1, 2014 - TheStreet.com
Heavy Trading On Tekmira Pharmaceuticals (TKMR) Before Market Open 8:22 a.m. Oct. 1, 2014 - TheStreet.com
October 1 Premarket Briefing: 10 Things You Should Know 6:49 a.m. Oct. 1, 2014 - TheStreet.com
Making Money With Charles Payne: 09/30/14 6:18 a.m. Oct. 1, 2014 - FOXBusiness
5 Ebola Stocks – Invest in Preventing a U.S. Ebola Outbreak 5:13 a.m. Oct. 1, 2014 - InvestorPlace.com
'Fast Money' Recap: Should You Invest in Ebola Vaccine Developers? 5:00 a.m. Oct. 1, 2014 - TheStreet.com
Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining in After-Hours Trading Today 5:11 p.m. Sept. 30, 2014 - TheStreet.com
Trade-Ideas: Tekmira Pharmaceuticals (TKMR) Is Today's Post-Market Leader Stock 4:52 p.m. Sept. 30, 2014 - TheStreet.com
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 6:11 a.m. Sept. 23, 2014 - GlobeNewswire
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola 9:15 a.m. Sept. 22, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
Ebola play Tekmira Pharmaceuticals shares drop 2.4% 9:35 a.m. Today - Sue Chang
Newscast: Stocks swoon to start October 6:27 p.m. Oct. 1, 2014 - MarketWatch
U.S. stocks skid; Russell 2000 in correction territory 4:34 p.m. Oct. 1, 2014 - Barbara Kollmeyer
Getting Ebola treatments to market may take time 3:04 p.m. Oct. 1, 2014 - Russ Britt
6 stocks to watch 2:08 p.m. Oct. 1, 2014 - The Trading Deck
Tekmira Pharmaceuticals shares jump 20% 9:33 a.m. Oct. 1, 2014 - Sue Chang
Profiting from the fear as the market’s best quarter of the year begins 8:58 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira may launch clinical trial of Ebola drug later this year: RBC 8:19 a.m. Oct. 1, 2014 - Ciara Linnane
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Sue Chang
Tekmira Pharmaceuticals shares up 27% in premarket trade 8:03 a.m. Oct. 1, 2014 - Ciara Linnane
FAA orders screen switch 2:33 a.m. Oct. 1, 2014 - MarketWatch
Tekmira Pharma shares pop on first U.S. Ebola case 7:43 p.m. Sept. 30, 2014 - Wallace Witkowski
Newscast: Wall Street notches winning quarter 6:31 p.m. Sept. 30, 2014 - MarketWatch
Tekmira shares jump 14% on report of U.S. Ebola case 4:48 p.m. Sept. 30, 2014 - Wallace Witkowski
End of QE turns institutions into sellers 3:19 p.m. Sept. 23, 2014 - The Trading Deck
Charting the bull-bear debate 11:50 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the bull-bear debate 11:32 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the next technical target: Dow 17,750 11:20 a.m. Sept. 18, 2014 - Michael Ashbaugh
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Today - Seeking Alpha
Tekmira Pharmaceuticals (TKMR) Is Today's Perilous Reversal Stock 9:48 a.m. Today - TheStreet.com
Thumbs Up for REITs, Down for Ebola Stocks? 7:42 a.m. Today - Barrons.com
Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% 4:39 p.m. Oct. 1, 2014 - GuruFocus.com
Stock Market Today: Stocks Dive With Utilities the Only Winning Sector 4:36 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Dow Drops 250 Points as Trouble Brews 3:29 p.m. Oct. 1, 2014 - TheStreet.com
3 Stocks Soaring on Spread of Ebola Virus Epidemic - Stocks in the News 1:48 p.m. Oct. 1, 2014 - Zacks.com
Ebola-Related Pharma Stocks Soar On First U.S. Case 1:20 p.m. Oct. 1, 2014 - Investors Business Daily
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today 12:22 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Stocks Decline as Investors Remain Uneasy 11:41 a.m. Oct. 1, 2014 - TheStreet.com
Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks 10:08 a.m. Oct. 1, 2014 - TheStreet.com
Today's Market: Biotech Stocks To Buy For Their Ebola Vaccines 9:35 a.m. Oct. 1, 2014 - Seeking Alpha
Stock Market Today: Futures Slip as U.S. Private Sector Adds Jobs 8:28 a.m. Oct. 1, 2014 - TheStreet.com
Heavy Trading On Tekmira Pharmaceuticals (TKMR) Before Market Open 8:22 a.m. Oct. 1, 2014 - TheStreet.com
October 1 Premarket Briefing: 10 Things You Should Know 6:49 a.m. Oct. 1, 2014 - TheStreet.com
Making Money With Charles Payne: 09/30/14 6:18 a.m. Oct. 1, 2014 - FOXBusiness
5 Ebola Stocks – Invest in Preventing a U.S. Ebola Outbreak 5:13 a.m. Oct. 1, 2014 - InvestorPlace.com
'Fast Money' Recap: Should You Invest in Ebola Vaccine Developers? 5:00 a.m. Oct. 1, 2014 - TheStreet.com
Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining in After-Hours Trading Today 5:11 p.m. Sept. 30, 2014 - TheStreet.com
Trade-Ideas: Tekmira Pharmaceuticals (TKMR) Is Today's Post-Market Leader Stock 4:52 p.m. Sept. 30, 2014 - TheStreet.com
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 6:11 a.m. Sept. 23, 2014 - GlobeNewswire
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola 9:15 a.m. Sept. 22, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
(0)
(0)